Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Seven facts that will set you straight for skin protection this summer
Despite a study’s finding, cancer and safety experts advise individuals to continue to wear sunscreen.
Chelsea Dawson, an eight-year melanoma survivor, lives with her family in Roanoke, Virginia.
Five ways the tanning and tobacco industries use the same playbook
Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma.
Using sun protection is a year-round, no exceptions recommendation.
Pembrolizumab led to 56 percent overall response rate for rare skin cancer.
Here are the cancer treatment news stories with the most views this year.
First-in-human pilot of experimental immunotherapy in Merkel cell carcinoma
An estimated 10 percent of people who access their records online end up requesting corrections—for a variety of reasons.
How a new technology solved a mystery and honors one man’s legacy
“The challenge now is to exploit this knowledge for therapeutics,” says researcher Joaquin Espinosa, PhD.
Cemiplimab is the first treatment for metastatic or locally advanced cutaneous squamous cell carcinoma.
In every issue of Cancer Health, you’ll find cutting-edge health information and the hottest topics of interest to people with cancer and th...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.